Category: Biolase Technology Inc.Syndicate content

Activist investor Oracle revives proxy war at Biolase

May 19, 2014 by Arezu Sarvestani

Oracle Partners issues a public statement to announce its "disappointment" over Biolase's Q1 results, which Biolase chairman & CEO Federico Pignatelli says is more evidence of the firm's attempts to take over the dental devices company.

Activist investor Oracle revives proxy war at Biolase

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

UPDATE: Court cuts Biolase board, marketing VP under fire

March 24, 2014 by Arezu Sarvestani

A Delaware state judge cuts the number of directors at Biolase and constrains the board's decision-making powers, as the dental device maker's claims about its sales & marketing vice president come under fire from a former employer amid a proxy war.

Court halves Biolase board, marketing VP under fire

*Updated March 25, 2014 at 10 a.m. Eastern with comment from Biolase sales & marketing vice president Brian Jaffe.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Proxy war brews as activist investor Oracle targets Biolase board

March 17, 2014 by Arezu Sarvestani

Biolase steadies itself against a proxy war filed by activist majority shareholder Oracle Partners over alleged manipulation of the board of directors.

Proxy war brews as activist investor Oracle targets Biolase leadership
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp